Spine Mainstay Medical to Showcase ReActiv8 and Key Clinical Data at the 13th German Spine Congress of the DWG byJosh SandbergDecember 4, 2018
Financial Neuro Mainstay Medical to seek further funding as full-year losses mount byJosh SandbergAugust 25, 2017
Hospitals Mainstay Medical Achieves CE Marking for ReActiv8® and Prepares for Commercial Launch in Germany byJosh SandbergJune 6, 2016
Hospitals Neuro Spine Mainstay Medical Gains Approval to Start US Clinical Trial of ReActiv8® byJosh SandbergJune 9, 2015
